Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

giant lymph node hyperplasia

(JY-unt limf node HY-per-PLAY-zhuh)
A rare disorder in which benign (not cancer) growths form in lymph node tissue. There are two main ways that giant lymph node hyperplasia occurs: localized (unicentric) and multicentric. Unicentric giant lymph node hyperplasia affects only one group of lymph nodes in one part of the body, usually in the chest or abdomen. It may not cause symptoms. Multicentric giant lymph node hyperplasia affects many groups of lymph nodes and lymphoid tissue all through the body. It can weaken the immune system and cause problems such as infection, fever, weight loss, fatigue, night sweats, nerve damage, and anemia. People with giant lymph node hyperplasia have an increased risk of lymphoma. Also called angiofollicular lymph node hyperplasia and Castleman disease.
Search NCI's Dictionary of Cancer Terms